Workflow
Biocause Pharma(000627)
icon
Search documents
*ST天茂(000627) - 关于公司股票停牌的进展公告
2025-09-14 07:45
天茂实业集团股份有限公司 关于公司股票停牌的进展公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导 性陈述或者重大遗漏。 证券代码:000627 证券简称:*ST天茂 公告编号:2025-058 特此公告。 天茂实业集团股份有限公司董事会 2025 年 9 月 15 日 1、截至目前,公司仍未披露 2024 年年度报告和 2025 年第一季度报告、2025 年半年度报 告。 2、公司于 2025 年 5 月 6 日披露了《关于收到中国证券监督管理委员会立案告知书的公告》 (公告编号:2025-015),公司收到中国证券监督管理委员会下发的《立案告知书》(证监立 案字 00502025004 号),因涉嫌未按期披露定期报告,根据《中华人民共和国证券法》《中 华人民共和国行政处罚法》等法律法规,2025 年 5 月 6 日,中国证券监督管理委员会决定对 公司立案。 3、《证券时报》《中国证券报》《上海证券报》和巨潮资讯网(www.cninfo.com.cn)为 公司选定的信息披露媒体,公司所有信息均以在上述媒体披露的信息为准,请广大投资者理性 投资,注意风险。 公司本次以股东会决议方式 ...
*ST天茂(000627) - 关于以股东会决议方式主动终止公司股票上市现金选择权行权暨实施的提示性公告
2025-09-14 07:45
证券代码:000627 证券简称:*ST天茂 公告编号:2025-057 天茂实业集团股份有限公司 关于以股东会决议方式主动终止公司股票上市 现金选择权行权暨实施的提示性公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏。 Delta值的绝对值未低于5%,根据《深圳证券交易所上市公司自律监管指南第1 号——业务办理》的相关规定,公司将采用交易系统方式提供现金选择权(系统 申报时显示为"现金选择权"业务),具体操作方式详见后文"三、申报行使现 金选择权的方式"之"(一)行权确认"。 4、本公告仅对现金选择权申报行权的有关事宜作出说明,不构成对申报行使 现金选择权的建议,提请广大投资者注意投资风险。 投资者欲了解本次以股东会决议方式主动终止上市的方案详情,应阅读公司于 2025年8月8日披露的《天茂实业集团股份有限公司关于撤回公司股票在深圳证券交 易所交易的方案》全文及相关文件,并及时关注公司发出的相关公告。 一、有权申报行使现金选择权的股东 特别提示: 1、天茂实业集团股份有限公司(以下简称"天茂集团"或"公司")股票 (证券简称:*ST天茂,证券代码:00062 ...
2025年1-7月贵州省原保险保费收入共计395.89亿元,同比增长2.88%
Chan Ye Xin Xi Wang· 2025-09-14 02:44
Core Insights - The insurance premium income in Guizhou Province from January to July 2025 reached 39.589 billion yuan, showing a year-on-year growth of 2.88% [1] - Life insurance accounted for the highest share of the total insurance premium income in Guizhou, amounting to 15.828 billion yuan, which represents 39.98% of the total [1] Company Insights - Listed companies mentioned include Tianmao Group (000627), China Ping An (601318), China Pacific Insurance (601601), China Life (601628), China Insurance (601319), and Xinhua Insurance (601336) [1] - The report by Zhiyan Consulting provides an analysis of the development and investment prospects of the Chinese insurance industry from 2025 to 2031 [1] Industry Insights - The cumulative original insurance premium income in Guizhou Province from 2020 to July 2025 is illustrated in a statistical chart [1] - Zhiyan Consulting is recognized as a leading industry consulting firm in China, specializing in in-depth industry research and providing comprehensive consulting services for investment decisions [1]
新股发行及今日交易提示-20250912
HWABAO SECURITIES· 2025-09-12 08:49
New Stock Issuance - YouSheng Co., Ltd. (Securities Code: 732418) issued shares at a price of 46.36 RMB on September 12, 2025[1] - *ST Tianmao (Securities Code: 000627) has a cash option declaration period from September 15 to September 19, 2025[1] - *ST Zitian (Securities Code: 300280) enters the delisting arrangement period starting September 15, 2025[1] Trading Alerts - Hangke Technology (Securities Code: 688006) reported severe abnormal fluctuations on September 11, 2025[1] - Shanghai Electric Power (Securities Code: 600021) had a trading volume of 8,487 on September 10, 2025[1] - Tianji Co., Ltd. (Securities Code: 002759) reported a trading volume of 8,705 on September 10, 2025[1] Abnormal Fluctuations - ST Lingnan (Securities Code: 002717) reported a trading volume of 7,965 on September 10, 2025[3] - ST Huaxi (Securities Code: 002630) reported a trading volume of 9,579 on September 11, 2025[3] - ST Jianye (Securities Code: 600381) reported a trading volume of 5,420 on September 3, 2025[3]
2025年1-7月江西省原保险保费收入共计819.93亿元,同比增长6.22%
Chan Ye Xin Xi Wang· 2025-09-12 03:20
Group 1 - The core viewpoint of the article highlights the growth of the insurance industry in Jiangxi Province, with a total original insurance premium income of 81.993 billion yuan from January to July 2025, representing a year-on-year increase of 6.22% [1] - Among different types of insurance, life insurance accounted for the highest share, totaling 46.192 billion yuan, which is 56.34% of the total premium income [1] - The article references a report by Zhiyan Consulting that analyzes the development and investment prospects of the Chinese insurance industry from 2025 to 2031 [1] Group 2 - The listed companies mentioned include Tianmao Group (000627), China Ping An (601318), China Pacific Insurance (601601), China Life (601628), China People’s Insurance (601319), and Xinhua Insurance (601336) [1] - Zhiyan Consulting is recognized as a leading industry consulting firm in China, providing in-depth industry research reports, business plans, feasibility studies, and customized services [1] - The data source for the insurance premium statistics is the National Financial Supervision Administration, organized by Zhiyan Consulting [1]
*ST天茂信披违规遭立案调查,拟启动主动退市程序
Core Viewpoint - *ST Tianmao has applied for voluntary delisting from the Shenzhen Stock Exchange, indicating significant operational and financial challenges faced by the company [2][5]. Group 1: Delisting Application - On September 11, 2025, *ST Tianmao announced that the Shenzhen Stock Exchange has accepted its application for voluntary delisting [2]. - The application for delisting was submitted on September 4, 2025, and the company received confirmation of acceptance from the exchange on September 10, 2025 [2]. Group 2: Financial Reporting Issues - On April 29, 2025, *ST Tianmao announced a delay in the release of its 2024 annual report and the 2025 Q1 report, citing the need for further information supplementation [3]. - This delay led to a significant market reaction, with the stock experiencing multiple trading halts due to investor concerns over the company's transparency [3]. Group 3: Financial Performance and Liquidity Risks - The company is facing substantial financial pressure, with a projected loss of between 500 million to 750 million yuan for the year 2024, primarily due to increased reserves at its subsidiary, Guohua Life [4]. - Guohua Life reported a high policy surrender amount of 20.6 billion yuan in 2023, with claims rising to 21.822 billion yuan in the first three quarters of 2024, exacerbating liquidity concerns for *ST Tianmao [4]. Group 4: Business Restructuring - On August 14, 2025, *ST Tianmao announced plans to initiate a voluntary delisting process due to significant uncertainties affecting its business structure [5]. - Following the delisting, the company intends to apply for transfer to the National Equities Exchange and Quotations (NEEQ) for trading in the delisted segment [5].
9月11日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-11 10:15
Group 1 - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% of the company's total shares, amounting to approximately 174 million shares [1] - Jinlongyu's shareholder terminates the share transfer agreement, halting the planned transfer of 5.32% of the company's shares [1] - Doli Technology's subsidiary plans to establish a joint venture in Spain with an investment of approximately 505 million yuan, with a 70% stake held by Doli Technology [1][2] Group 2 - Chongqing Pharmaceutical, a subsidiary of Zhongyao Holdings, has received approval for clinical trials of its drug, Clopidogrel Hydrochloride Tablets [3][4] - Dongyangguang plans to jointly increase capital in a subsidiary to acquire 100% of Qinhuai Data China for 28 billion yuan [5] - Kangzhi Pharmaceutical's controlling shareholder intends to transfer 5.0004% of the company's shares at a price of 5.34 yuan per share, totaling approximately 122 million yuan [6] Group 3 - Huali Co., Ltd. announces two shareholders plan to reduce their stakes by a combined total of up to 3.96% of the company's shares [7] - Fangbang Co., Ltd.'s director plans to reduce his stake by up to 15,000 shares, representing 0.1844% of the total shares [8] - China Pacific Insurance suggests issuing HKD-denominated convertible bonds, with proceeds aimed at supporting its main insurance business and strategic initiatives [9] Group 4 - Microchip Biotech's shareholder plans to reduce its stake by up to 3% of the company's total shares [10] - Hongbai New Materials' controlling shareholder intends to reduce its stake by up to 3% due to funding needs [11] - Zhejiang Rongtai clarifies that its sales in the robotics components sector are minimal and will not significantly impact annual net profit [12] Group 5 - ST Tianmao voluntarily withdraws its application for A-share listing, which has been accepted by the Shenzhen Stock Exchange [13] - Qingxin Environment's shareholder plans to reduce its stake by up to 1% of the company's total shares [14] - Lanjik Technology's two shareholders plan to reduce their stakes by a combined total of up to 2% of the company's shares [15] Group 6 - BYD's executives and core personnel collectively increased their holdings in the company by approximately 52.33 million yuan [16] - Trina Solar's subsidiary signs contracts for the sale of 2.48 GWh of energy storage products, marking a significant overseas order [17] - Chutianlong's shareholder plans to reduce its stake by up to 3% of the company's total shares [18] Group 7 - Zhongjuxin's shareholder plans to reduce its stake by up to 2.5% of the company's total shares due to funding needs [19] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [20] - Shoukai Co., Ltd. reports a signed contract amount of 973 million yuan for August, with cumulative contracts of 13.15 billion yuan for the year [21] Group 8 - Jucheng Co., Ltd.'s shareholder plans to reduce its stake by up to 2.61% of the company's total shares due to personal funding needs [22]
新股发行及今日交易提示-20250911
HWABAO SECURITIES· 2025-09-11 09:43
New Stock Issuance - The new stock issued by Haocreat Technology (证券代码: 301668) is priced at 21.00 RMB per share, effective from September 11, 2025[1] - Cash option declaration period for *ST Tianmao (证券代码: 000627) is from September 15 to September 19, 2025[1] - *ST Zitian (证券代码: 300280) will enter the delisting arrangement period starting September 15, 2025[1] Market Alerts - Significant abnormal fluctuations reported for Kaipu Cloud (证券代码: 688228) on September 11, 2025[1] - The latest announcements for various stocks can be accessed through the provided links, indicating ongoing market activity and updates[1] Trading Updates - Multiple stocks including Shanghai Electric (证券代码: 600021) and Tianji Shares (证券代码: 002759) have recent announcements affecting their trading status[1] - The report includes a comprehensive list of stocks with their respective announcements and trading updates, reflecting the dynamic nature of the market[1]
天茂实业集团股份有限公司 关于深圳证券交易所受理公司 股票主动终止上市申请的公告
天茂实业集团股份有限公司 证券代码:000627 证券简称:*ST天茂 公告编号:2025-056 公司将在深交所作出公司股票终止上市的决定后刊登终止上市公告。敬请广大投资者注意投资风险。 特此公告。 天茂实业集团股份有限公司董事会 2025 年 9 月 10 日 天茂实业集团股份有限公司(以下简称"天茂集团"或"公司")拟以股东会决议方式主动撤回A股股票在 深圳证券交易所(以下简称"深交所")的上市交易,并在股票终止上市后申请转入全国中小企业股份转 让系统有限责任公司代为管理的退市板块转让(以下简称"本次终止上市")。本次终止上市事项已于 2025年8月25日经公司2025年第一次临时股东会审议通过。 根据《深交所股票上市规则》的相关要求,公司已于2025年9月4日向深交所提交了本次终止上市申请。 2025年9月10日,公司收到深交所《关于同意受理天茂实业集团股份有限公司股票终止上市申请的函》 (公司部函〔2025〕第281号),深交所正式受理公司股票终止上市申请。 根据《深交所股票上市规则》的相关规定,深交所在受理公司申请后的十五个交易日内,深交所上市委 员会形成审议意见。深交所将根据上市委员会的审议意见 ...
每天三分钟公告很轻松|600673,并购大动作
Group 1 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of 100% equity in Qinhuai Data China, with a total investment of 75 billion yuan [2] - Baiyin Nonferrous Metals is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [3] - Beida Pharmaceutical intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [5] Group 2 - ST Tianmao plans to withdraw its A-share listing and transfer to the National SME Share Transfer System after delisting [5] - Goldwind Technology has approved an investment agreement for a 3GW wind-hydrogen-ammonia integration project in Inner Mongolia, with a total investment of approximately 189.2 billion yuan [6] - Langzi Co. has signed an agreement to acquire 67.5% of Chongqing Milan Baiyu Shiguang Medical Beauty Hospital for 92.475 million yuan [7] Group 3 - Dongfang Guoxin is establishing a joint venture with Beijing Shunyi Financial Holdings to focus on computing power infrastructure and services, with a registered capital of 300 million yuan [8] - ST Hezhong's chairman is under bail pending trial, but the company's operations remain unaffected [9] - Kangzhi Pharmaceutical's major shareholder is transferring 22.758 million shares at a price of 5.34 yuan per share, totaling 122 million yuan [9] Group 4 - Shenzhen Airport reported a passenger throughput of 5.807 million in August, a year-on-year increase of 4.07% [10] - Lin Yang Energy won a bid for a project with a total amount of approximately 244.08 million yuan [11] - Fullpower New Materials received a government subsidy of 20 million yuan, which is expected to positively impact its 2025 profits [14] Group 5 - BYD executives and core personnel collectively increased their holdings by 48.82 million shares, totaling 52.3278 million yuan [16] - Hualing Steel's major shareholder increased its stake by 6.90862 million shares, representing a 1% increase in ownership [16]